日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acute myeloid leukemia with t(10;17)(p15;q21)/ ZMYND11::MBTD1: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults

t(10;17)(p15;q21)/ZMYND11::MBTD1 型急性髓系白血病:一种分化程度低、CD7/CD56 表达阳性且成人预后通常较差的亚型

Wei, Qing; Pemmaraju, Naveen; Wang, Sa A; Hu, Shimin; Dinardo, Courtney; Issa, Ghayas C; Bueso-Ramos, Carlos E; Xu, Jie; Li, Shaoying; Medeiros, L Jeffrey; Tang, Guilin

Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效

Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval

High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition

利用高通量蛋白质组学分析评估 Menin 抑制剂引起的分化综合征

Garcia, Miriam B; Wang, Bofei; Sheikh, Irtiza; El Hajjar, Georgina; McCall, David; Nunez, Cesar; Gibson, Amber; Lorenzi, Philip L; Issa, Ghayas C; Cuglievan, Branko; Abbas, Hussein A

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML

Ziftomenib治疗复发或难治性NPM1突变型急性髓系白血病

Wang, Eunice S; Montesinos, Pau; Foran, James; Erba, Harry; Rodríguez-Arbolí, Eduardo; Fedorov, Kateryna; Heiblig, Maël; Heidel, Florian H; Altman, Jessica K; Baer, Maria R; Ades, Lionel; Pettit, Kristen; Peterlin, Pierre; Papayannidis, Cristina; Berthon, Céline; Walter, Roland B; Shah, Mithun V; Balasubramanian, Suresh; Khawandanah, Mohamad; Salamero Garcia, Olga; Bergeron, Julie; Madanat, Yazan F; Roboz, Gail J; Ulrickson, Matthew; Redner, Robert L; McCloskey, James; Pigneux, Arnaud; de la Fuente Burguera, Adolfo; Mitra, Amitava; Soifer, Harris S; Tabachri, Marilyn; Zhang, Zijing; Riches, Marcie; Corum, Daniel; Leoni, Mollie; Issa, Ghayas C; Fathi, Amir T

Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML

对于不适合接受强化化疗的异柠檬酸脱氢酶突变型急性髓系白血病患者,一线三联疗法(包括去甲基化药物、维奈托克和异柠檬酸脱氢酶抑制剂)的疗效

DiNardo, Courtney D; Marvin-Peek, Jennifer; Loghavi, Sanam; Takahashi, Koichi; Issa, Ghayas C; Jen, Wei-Ying; Daver, Naval G; Reville, Patrick K; Short, Nicholas J; Sasaki, Koji; Mullin, Jillian K; Bradley, Corey A; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Abbas, Hussein A; Hammond, Danielle E; Haddad, Fadi; Bravo, Guillermo Montalban; Chien, Kelly S; Yilmaz, Musa; Kornblau, Steven M; Jabbour, Elias; Ravandi, Farhad; Kadia, Tapan; Garcia-Manero, Guillermo; Konopleva, Marina Y; Kantarjian, Hagop M

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

DS-1594 menin抑制剂治疗复发/难治性急性白血病的1/2期研究

Senapati, Jayastu; Konopleva, Marina; Issa, Ghayas C; Jabbour, Elias; Kadia, Tapan; DiNardo, Courtney; Borthakur, Gautam; Pemmaraju, Naveen; Short, Nicholas J; Yilmaz, Musa; Deshmukh, Indraneel; Alvarez, Joie; Loghavi, Sanam; Tang, Guilin; Abbas, Hussein A; Andreeff, Michael; Bhalla, Kapil; Midde, Narasimha M; Said, Nabil; Noyalis, Amy; Mires, Derek E; Ning, Jing; Xiao, Lianchun; Ravandi, Farhad; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Daver, Naval G

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

使用revumenib抑制Menin治疗NPM1突变复发或难治性急性髓系白血病:AUGMENT-101研究

Arellano, Martha L; Thirman, Michael J; DiPersio, John F; Heiblig, Maël; Stein, Eytan M; Schuh, Andre C; Žučenka, Andrius; de Botton, Stephane; Grove, Carolyn S; Mannis, Gabriel N; Papayannidis, Cristina; Perl, Alexander E; Issa, Ghayas C; Aldoss, Ibrahim; Bajel, Ashish; Dickens, David S; Kühn, Michael W M; Mantzaris, Ioannis; Raffoux, Emmanuel; Traer, Elie; Amitai, Irina; Döhner, Hartmut; Greco, Corinna; Kovacsovics, Tibor; McMahon, Christine M; Montesinos, Pau; Pigneux, Arnaud; Shami, Paul J; Stone, Richard M; Wolach, Ofir; Harpel, John G; Chudnovsky, Yakov; Yu, Li; Bagley, Rebecca G; Smith, Angela R; Blachly, James S

How I treat acute myeloid leukemia with differentiation therapy

我如何运用分化疗法治疗急性髓系白血病

Issa, Ghayas C; Stein, Eytan M; DiNardo, Courtney D

Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition

鸟嘌呤核苷酸生物合成阻断会损害 MLL 复合物的形成,并使白血病对 menin 抑制剂更加敏感。

Xiangguo Shi ,Minhua Li,Zian Liu,Jonathan Tiessen,Yuan Li,Jing Zhou,Yudan Zhu,Swetha Mahesula,Qing Ding,Lin Tan,Mengdie Feng,Yuki Kageyama,Yusuke Hara,Jacob J Tao,Xuan Luo,Kathryn A Patras,Philip L Lorenzi,Suming Huang,Alexandra M Stevens,Koichi Takahashi,Ghayas C Issa,Md Abul Hassan Samee,Michalis Agathocleous,Daisuke Nakada      0